Spider Rock Advisors, LLC Ionis Pharmaceuticals Inc Transaction History
Spider Rock Advisors, LLC
- $6.17 Billion
- Q3 2024
A detailed history of Spider Rock Advisors, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Spider Rock Advisors, LLC holds 12,036 shares of IONS stock, worth $380,819. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,036
Previous 12,026
0.08%
Holding current value
$380,819
Previous $573,000
15.88%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding IONS
# of Institutions
409Shares Held
136MCall Options Held
862KPut Options Held
617K-
Vanguard Group Inc Valley Forge, PA15.1MShares$476 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$448 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$327 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$276 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$249 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.49B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...